We are Epilepsy Society. The UK’s only charity transforming the lives of people with epilepsy through world-leading research, advocacy and care.
Medical services
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
Care services
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Campaigns
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online trolling, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy.
Latest news
Charities call on Health Secretary to carry out urgent review of medicines supply chain
The Epilepsy Society is calling on Health Secretary Victoria Atkins to carry out an urgent review of the medicines supply chain as our own survey, carried out with other health charities, shows the struggles that people are experiencing in accessing life-saving medication.
O2 confirms its advert has passed photosensitive epilepsy safety tests
We reached out to mobile network O2 this week after a number of people with epilepsy contacted us with concerns about strobe lighting in its recent advert.
Charities and pharmacists call for medicine supply chain review as shortages continue
The Epilepsy Society has joined forces with other health charities and pharmacists to tell the government to fix the medicines supply chain as new data shows drug shortages are putting patients’ health at risk.
Meds shortages: have your say
The Epilepsy Society has launched our official Medication Shortage Survey, alongside Epilepsy Action, SUDEP Action and Parkinson's UK. Have your say now!
Zach's Law: celebrating a great campaign
We had a truly remarkable celebration of our Zach’s Law campaign last week, with Zach meeting the Prime Minister, Rishi Sunak, and Leader of the Opposition, Sir Keir Starmer, and having photographs taken at 10 Downing Street.
Epilepsy Society welcomes redress scheme for valproate victims but says research is also vital
Today, Patient Safety Commissioner, Dr Henrietta Hughes, launched The Hughes Report calling for redress for all those harmed by valproate. The Epilepsy Society has warmly welcomed Dr Hughes' recommendations but warned that research into other epilepsy medications is also vital to stop history from repeating itself with other drugs.
Our research
Research
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
We're open:
Monday and Wednesday - 9am to 7.30pm
Tuesday, Thursday, and Friday - 9am to 4pm
Saturday - 9am to 12.30pm
You can also reach us by email
helpline@epilepsysociety.org.uk.